Syndax Pharmaceuticals (NasdaqGS:SNDX) Q3 2025 Earnings Call November 03, 2025 04:30 PM ET Speaker1Good day, everyone, and welcome to the Syndax Q3 2025 earnings conference call. Today's call is being recorded. If you would like to ask a question following the company's prepared remarks, please press star five during the call. At this time, I would like to turn the call over to Sharon Clary, Head of Investor Relations at Syndax Pharmaceuticals.Speaker0Thank you, Operator. Welcome, and thank you all for join ...

Third Quarter Financial Results Presentation / November 3, 2025 Forward-looking statements disclosure This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "may," "will," "expect," "plan," "anticipate" and similar expressions (as well as other words or expressions referencing future events, progress, timing or circumstances) are intended to identify forward-looking statements. All statements other than statements of hi ...